Conference / Tradeshow

Cell & Gene Therapy Europe – Manufacturing & Commercialization


Monday, November 29, 2021 - Thursday, December 9, 2021


Attendee at Cell & Gene Therapy Europe – Manufacturing & Commercialization

Event Overview

Join us at Informa’s Cell and Gene Therapy Europe – Manufacturing & Commercialization from November 29 - December 9, 2021. This digital conference is a free-to-attend webinar series spanning three tracks:

  1. Cell Therapy
  2. Gene Edited Ex Vivo Cell Therapy
  3. In Vivo Gene Therapy

Matthew Hewitt Headshot

Matthew Hewitt
Director of Scientific Services
Cell and Gene Therapy,

Charles River Laboratories

Featured Presentation:

Cell & Gene Therapy Matures: Streamlining and Smoothing the Path to Commercialization

The cell and gene therapy (CGT) industry is coming of age with multiple approved products in both AAV and gene-modified cell therapy. As the field continues to grow and mature, the advantages of integrated products and solutions for therapeutic developers is becoming apparent. Typically CGT program development requires managing multiple relationships and this presents challenges in aligning timelines. In this talk learn how Charles River's portfolio of products and services helps to enable our partners to streamline their path to commercialization.